KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cardinal Health (CAH) Income from Non-Controlling Interests (2016 - 2025)

Cardinal Health's Income from Non-Controlling Interests history spans 10 years, with the latest figure at $4.0 million for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests rose 300.0% year-over-year to $4.0 million; the TTM value through Sep 2025 reached $8.0 million, up 100.0%, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Income from Non-Controlling Interests for Q3 2025 was $4.0 million at Cardinal Health, up from $2.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q3 2025 and bottomed at -$1.0 million in Q2 2022.
  • The 4-year median for Income from Non-Controlling Interests is $1.0 million (2022), against an average of $1.4 million.
  • The largest YoY upside for Income from Non-Controlling Interests was 300.0% in 2025 against a maximum downside of 300.0% in 2025.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at $1.0 million in 2022, then skyrocketed by 100.0% to $2.0 million in 2023, then crashed by 50.0% to $1.0 million in 2024, then soared by 300.0% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Income from Non-Controlling Interests are $4.0 million (Q3 2025), $2.0 million (Q1 2025), and $1.0 million (Q4 2024).